NEW YORK (GenomeWeb News) — Luminex today said fourth-quarter revenue increased 23 percent as R&D spending rose 43 percent as it swung to a profit.
 
News of the earnings caused shares in the company to surge 30 percent, or $3.76, to $16.49 in early-afternoon trading today.
 
Total receipts for the three months ended Dec. 31, 2006, increased to $14.2 million from $11.6 million year over year.
 
R&D spending increased to $2.3 million from $1.6 million year over year.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.